Vault-13

PERCEPTIVE ADVISORS LLC

NEW YORK, NY · CIK 1224962 · 13F filing filed 2021-08-16

SEC-registered investment adviser since 2010 · limited liability company

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 25
Greenwich, CTUnited States United States1
Miami Beach, FLUnited States United States1
Sheridan, WYUnited States United States1
Water Mill, NYUnited States United States

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$15.4bn reported value +104.2% vs Q1 2021
148positions
39.2%in top 10
29 new 112 added 6 reduced 17 sold out vs Q1 2021

Options: 1 call positions ($33.3m notional), 1 put positions ($166.0k notional) – listed below, not included above.

Holdings, Q2 2021

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 MIRATI THERAPEUTICS INC COM MRTX MRTX 6,371,796 $1.0bn6.70% 6.70% AddedShares held: Q3 2020 3.4m, Q4 2020 3.7m, Q1 2021 3.5m, Q2 2021 6.4m +2.9m +2,897,291 83.4%
2 BRIDGEBIO PHARMA INC COM BBIO BBIO 15,513,856 $945.7m6.16% 6.16% AddedShares held: Q3 2020 6.7m, Q4 2020 6.7m, Q1 2021 7.8m, Q2 2021 15.5m +7.8m +7,756,928 100.0%
3 SPRINGWORKS THERAPEUTICS INC COM SWTX SWTX 9,699,824 $799.4m5.20% 5.20% AddedShares held: Q3 2020 3.5m, Q4 2020 4.2m, Q1 2021 4.8m, Q2 2021 9.7m +4.8m +4,849,912 100.0%
4 RETROPHIN INC NOTE 2.500% 9/1 · principal TVTX 2.5 09.15.25 · principal TVTX 2.5 09.15.25 90,000,000 $768.8m5.00% 5.00% AddedPrincipal held: Q3 2020 45.0m, Q4 2020 45.0m, Q1 2021 45.0m, Q2 2021 90.0m +45.0m +45,000,000 100.0%
5 IOVANCE BIOTHERAPEUTICS INC COM IOVA IOVA 21,919,544 $570.3m3.71% 3.71% AddedShares held: Q3 2020 10.1m, Q4 2020 9.2m, Q1 2021 8.7m, Q2 2021 21.9m +13.3m +13,267,759 153.3%
6 AMICUS THERAPEUTICS INC COM FOLD FOLD 46,242,658 $445.8m2.90% 2.90% AddedShares held: Q3 2020 25.1m, Q4 2020 25.1m, Q1 2021 22.9m, Q2 2021 46.2m +23.4m +23,381,329 102.3%
7 COLLEGIUM PHARMACEUTICAL INC NOTE 2.625% 2/1 · principal COLL 2.625 02.15.26 · principal COLL 2.625 02.15.26 35,000,000 $379.4m2.47% 2.47% AddedPrincipal held: Q3 2020 17.5m, Q4 2020 17.5m, Q1 2021 17.5m, Q2 2021 35.0m +17.5m +17,500,000 100.0%
8 HORIZON THERAPEUTICS PUB L SHS HZNP HZNP 3,970,004 $371.8m2.42% 2.42% AddedShares held: Q3 2020 0, Q4 2020 3.1m, Q1 2021 2.1m, Q2 2021 4.0m +1.9m +1,920,002 93.7%
9 VBI VACCINES INC CDA COM NEW COM NEW 110,084,930 $368.8m2.40% 2.40% AddedShares held: Q3 2020 55.0m, Q4 2020 55.0m, Q1 2021 55.0m, Q2 2021 110.1m +55.0m +55,042,465 100.0%
10 LANDOS BIOPHARMA INC COM COM 29,739,830 $343.5m2.24% 2.24% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 14.9m, Q2 2021 29.7m +14.9m +14,869,915 100.0%
11 INVITAE CORP COM NVTA NVTA 9,637,602 $325.1m2.12% 2.12% AddedShares held: Q3 2020 0, Q4 2020 7.3m, Q1 2021 5.4m, Q2 2021 9.6m +4.3m +4,276,929 79.8%
12 NEVRO CORP NOTE 2.750% 4/0 · principal NVRO 2.75 04.01.25 · principal NVRO 2.75 04.01.25 18,000,000 $312.6m2.03% 2.03% AddedPrincipal held: Q3 2020 9.0m, Q4 2020 9.0m, Q1 2021 9.0m, Q2 2021 18.0m +9.0m +9,000,000 100.0%
13 ZYMEWORKS INC COM ZYME ZYME 8,611,200 $298.7m1.94% 1.94% AddedShares held: Q3 2020 4.4m, Q4 2020 4.3m, Q1 2021 4.3m, Q2 2021 8.6m +4.3m +4,280,332 98.8%
14 GLOBAL BLOOD THERAPEUTICS IN COM GBT GBT 8,305,378 $290.9m1.89% 1.89% AddedShares held: Q3 2020 5.8m, Q4 2020 5.7m, Q1 2021 5.1m, Q2 2021 8.3m +3.2m +3,246,736 64.2%
15 NEVRO CORP COM NVRO NVRO 1,637,520 $271.5m1.77% 1.77% AddedShares held: Q3 2020 826.2k, Q4 2020 977.6k, Q1 2021 812.2k, Q2 2021 1.6m +825.4k +825,366 101.6%
16 ROCKET PHARMACEUTICALS INC COM RCKT RCKT 5,503,206 $243.7m1.59% 1.59% AddedShares held: Q3 2020 2.2m, Q4 2020 3.4m, Q1 2021 2.9m, Q2 2021 5.5m +2.6m +2,635,435 91.9%
17 OUTSET MED INC COM OM OM 4,775,070 $238.7m1.55% 1.55% AddedShares held: Q3 2020 2.8m, Q4 2020 2.8m, Q1 2021 2.4m, Q2 2021 4.8m +2.4m +2,387,535 100.0%
18 CEREVEL THERAPEUTICS HLDNG I COM CERE CERE 9,286,190 $237.9m1.55% 1.55% AddedShares held: Q3 2020 0, Q4 2020 4.5m, Q1 2021 4.6m, Q2 2021 9.3m +4.6m +4,643,095 100.0%
19 ALDEYRA THERAPEUTICS INC COM ALDX ALDX 19,807,758 $224.4m1.46% 1.46% AddedShares held: Q3 2020 6.3m, Q4 2020 6.3m, Q1 2021 8.7m, Q2 2021 19.8m +11.1m +11,103,879 127.6%
20 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 1,233,604 $221.3m1.44% 1.44% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 175.0k, Q2 2021 1.2m +1.1m +1,058,604 604.9%
21 MEIRAGTX HLDGS PLC COM MGTX MGTX 13,896,554 $215.4m1.40% 1.40% AddedShares held: Q3 2020 6.4m, Q4 2020 6.9m, Q1 2021 6.9m, Q2 2021 13.9m +7.0m +6,963,277 100.4%
22 NAUTILUS BIOTECHNOLOGY INC COM NAUT NAUT 17,822,302 $180.0m1.17% 1.17% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 17.8m
23 C4 THERAPEUTICS INC COM STK CCCC CCCC 4,517,132 $170.9m1.11% 1.11% AddedShares held: Q3 2020 0, Q4 2020 3.2m, Q1 2021 3.2m, Q2 2021 4.5m +1.4m +1,358,566 43.0%
24 SINGULAR GENOMICS SYSTEMS IN COM COM 6,165,740 $169.4m1.10% 1.10% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 6.2m
25 ALBIREO PHARMA INC COM BIOD BIOD 4,720,278 $166.1m1.08% 1.08% AddedShares held: Q3 2020 2.4m, Q4 2020 2.4m, Q1 2021 2.4m, Q2 2021 4.7m +2.4m +2,360,139 100.0%
26 PROMETHEUS BIOSCIENCES INC COM COM 6,628,064 $162.8m1.06% 1.06% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 3.3m, Q2 2021 6.6m +3.3m +3,314,032 100.0%
27 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 1,623,664 $158.0m1.03% 1.03% AddedShares held: Q3 2020 1.5m, Q4 2020 1.9m, Q1 2021 941.8k, Q2 2021 1.6m +681.8k +681,832 72.4%
28 RAPT THERAPEUTICS INC COM COM 4,951,320 $157.4m1.02% 1.02% AddedShares held: Q3 2020 0, Q4 2020 1.6m, Q1 2021 2.5m, Q2 2021 5.0m +2.5m +2,473,839 99.8%
29 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 7,927,034 $149.4m0.97% 0.97% AddedShares held: Q3 2020 3.7m, Q4 2020 3.7m, Q1 2021 3.7m, Q2 2021 7.9m +4.3m +4,267,653 116.6%
30 RELAY THERAPEUTICS INC COM RLAY RLAY 4,036,194 $147.7m0.96% 0.96% AddedShares held: Q3 2020 2.3m, Q4 2020 2.3m, Q1 2021 2.0m, Q2 2021 4.0m +2.0m +2,018,097 100.0%
31 BEAM THERAPEUTICS INC COM BEAM BEAM 1,075,270 $138.4m0.90% 0.90% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 537.6k, Q2 2021 1.1m +537.6k +537,635 100.0%
32 ZYMERGEN INC COM ZY ZY 3,266,664 $130.7m0.85% 0.85% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 3.3m
33 COHERUS BIOSCIENCES INC COM CHRS CHRS 9,395,224 $129.9m0.85% 0.85% AddedShares held: Q3 2020 3.6m, Q4 2020 4.7m, Q1 2021 4.7m, Q2 2021 9.4m +4.7m +4,697,612 100.0%
34 ATHENEX INC COM ATNX ATNX 27,064,934 $125.0m0.81% 0.81% AddedShares held: Q3 2020 13.5m, Q4 2020 13.5m, Q1 2021 13.5m, Q2 2021 27.1m +13.5m +13,532,467 100.0%
35 ESTABLISHMENT LABS HLDGS INC COM ESTA ESTA 1,400,816 $122.3m0.80% 0.80% AddedShares held: Q3 2020 678.6k, Q4 2020 696.6k, Q1 2021 987.3k, Q2 2021 1.4m +413.5k +413,529 41.9%
36 KADMON HLDGS INC COM KDMN KDMN 31,422,668 $121.6m0.79% 0.79% AddedShares held: Q3 2020 15.7m, Q4 2020 15.7m, Q1 2021 15.7m, Q2 2021 31.4m +15.7m +15,711,334 100.0%
37 KRONOS BIO INC COM KRON KRON 5,056,104 $121.1m0.79% 0.79% AddedShares held: Q3 2020 0, Q4 2020 2.8m, Q1 2021 2.8m, Q2 2021 5.1m +2.3m +2,276,007 81.9%
38 QUOTIENT LTD SHS SHS 32,401,636 $117.9m0.77% 0.77% AddedShares held: Q3 2020 16.2m, Q4 2020 16.2m, Q1 2021 16.2m, Q2 2021 32.4m +16.2m +16,200,818 100.0%
39 MACROGENICS INC COM MGNX MGNX 4,296,120 $115.4m0.75% 0.75% AddedShares held: Q3 2020 1.3m, Q4 2020 1.3m, Q1 2021 2.1m, Q2 2021 4.3m +2.1m +2,148,060 100.0%
40 MEDTRONIC PLC SHS MDT MDT 900,000 $111.7m0.73% 0.73% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 900.0k
41 MORPHIC HLDG INC COM MORF MORF 1,876,280 $107.7m0.70% 0.70% AddedShares held: Q3 2020 487.0k, Q4 2020 487.0k, Q1 2021 938.1k, Q2 2021 1.9m +938.1k +938,140 100.0%
42 SOLID BIOSCIENCES INC COM COM 26,825,104 $98.2m0.64% 0.64% AddedShares held: Q3 2020 6.7m, Q4 2020 10.8m, Q1 2021 13.4m, Q2 2021 26.8m +13.4m +13,412,552 100.0%
43 ATEA PHARMACEUTICALS INC COM AVIR AVIR 4,518,448 $97.1m0.63% 0.63% AddedShares held: Q3 2020 0, Q4 2020 3.1m, Q1 2021 3.1m, Q2 2021 4.5m +1.4m +1,409,224 45.3%
44 COHERUS BIOSCIENCES INC NOTE 1.500% 4/1 · principal CHRS 1.5 04.15.26 · principal CHRS 1.5 04.15.26 9,000,000 $92.1m0.60% 0.60% NewPrincipal held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 9.0m
45 CAREMAX INC COM CL A COM CL A 6,640,000 $85.7m0.56% 0.56% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 6.6m
46 DBV TECHNOLOGIES S A SPONSORED ADR SPONSORED ADR 15,391,010 $84.0m0.55% 0.55% AddedShares held: Q3 2020 6.8m, Q4 2020 6.6m, Q1 2021 7.7m, Q2 2021 15.4m +7.7m +7,695,505 100.0%
47 APELLIS PHARMACEUTICALS INC COM APLS APLS 1,322,324 $83.6m0.54% 0.54% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.3m
48 VERRICA PHARMACEUTICALS INC COM COM 7,220,824 $81.6m0.53% 0.53% AddedShares held: Q3 2020 3.4m, Q4 2020 3.4m, Q1 2021 3.6m, Q2 2021 7.2m +3.6m +3,610,412 100.0%
49 RAIN ONCOLOGY INC COM COM 5,074,038 $78.8m0.51% 0.51% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 5.1m
50 TREACE MED CONCEPTS INC COM TMCI TMCI 2,471,772 $77.3m0.50% 0.50% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 2.5m
51 TARSUS PHARMACEUTICALS INC COM TARS TARS 2,592,832 $75.1m0.49% 0.49% AddedShares held: Q3 2020 0, Q4 2020 1.3m, Q1 2021 1.3m, Q2 2021 2.6m +1.3m +1,296,416 100.0%
52 AXSOME THERAPEUTICS INC COM AXSM AXSM 1,107,816 $74.7m0.49% 0.49% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.1m
53 VERU INC COM COM 8,902,684 $71.8m0.47% 0.47% AddedShares held: Q3 2020 1.6m, Q4 2020 3.2m, Q1 2021 4.5m, Q2 2021 8.9m +4.5m +4,451,342 100.0%
54 ATHIRA PHARMA INC COM COM 6,851,832 $70.2m0.46% 0.46% AddedShares held: Q3 2020 3.1m, Q4 2020 3.1m, Q1 2021 3.4m, Q2 2021 6.9m +3.4m +3,425,916 100.0%
55 HEALTH CATALYST INC COM HCAT HCAT 1,132,168 $62.8m0.41% 0.41% AddedShares held: Q3 2020 291.1k, Q4 2020 276.1k, Q1 2021 506.1k, Q2 2021 1.1m +626.1k +626,084 123.7%
56 XENON PHARMACEUTICALS INC COM XENE XENE 3,357,946 $62.5m0.41% 0.41% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 515.0k, Q2 2021 3.4m +2.8m +2,842,904 552.0%
57 DICERNA PHARMACEUTICALS INC COM DRNA DRNA 1,600,000 $59.7m0.39% 0.39% AddedShares held: Q3 2020 800.0k, Q4 2020 800.0k, Q1 2021 800.0k, Q2 2021 1.6m +800.0k +800,000 100.0%
58 BIOATLA INC COM BCAB BCAB 1,371,038 $58.1m0.38% 0.38% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.4m
59 EXACT SCIENCES CORP COM EXAS EXAS 467,046 $58.1m0.38% 0.38% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 353.5k, Q2 2021 467.0k +113.5k +113,523 32.1%
60 IMMATICS N.V SHS IMTX IMTX 5,000,000 $58.0m0.38% 0.38% AddedShares held: Q3 2020 2.5m, Q4 2020 2.5m, Q1 2021 2.5m, Q2 2021 5.0m +2.5m +2,500,000 100.0%
61 INARI MED INC COM NARI NARI 620,874 $57.9m0.38% 0.38% AddedShares held: Q3 2020 848.5k, Q4 2020 668.5k, Q1 2021 565.1k, Q2 2021 620.9k +55.8k +55,761 9.9%
62 IVERIC BIO INC COM OPHT OPHT 9,171,024 $57.9m0.38% 0.38% AddedShares held: Q3 2020 3.5m, Q4 2020 4.5m, Q1 2021 4.6m, Q2 2021 9.2m +4.6m +4,585,512 100.0%
63 ACCELERON PHARMA INC COM XLRN XLRN 453,520 $56.9m0.37% 0.37% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 453.5k
64 NUVATION BIO INC COM CL A NUVB NUVB 6,082,008 $56.6m0.37% 0.37% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 3.0m, Q2 2021 6.1m +3.0m +3,041,004 100.0%
65 ALPHATEC HLDGS INC COM NEW ATEC ATEC 3,600,360 $55.2m0.36% 0.36% AddedShares held: Q3 2020 561.6k, Q4 2020 0, Q1 2021 1.8m, Q2 2021 3.6m +1.8m +1,800,180 100.0%
66 TRAVERE THERAPEUTICS INC COM TVTX TVTX 3,691,110 $53.9m0.35% 0.35% AddedShares held: Q3 2020 0, Q4 2020 3.5m, Q1 2021 3.3m, Q2 2021 3.7m +392.7k +392,691 11.9%
67 GRAPHITE BIO INC COM GRPH GRPH 1,750,186 $53.8m0.35% 0.35% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.8m
68 AVIDITY BIOSCIENCES INC COM RNA RNA 2,158,056 $53.3m0.35% 0.35% AddedShares held: Q3 2020 1.2m, Q4 2020 1.2m, Q1 2021 1.1m, Q2 2021 2.2m +1.1m +1,059,028 96.4%
69 KODIAK SCIENCES INC COM KOD KOD 572,082 $53.2m0.35% 0.35% AddedShares held: Q3 2020 1.0m, Q4 2020 751.5k, Q1 2021 389.0k, Q2 2021 572.1k +183.1k +183,074 47.1%
70 ADMA BIOLOGICS INC COM ADMA ADMA 33,169,604 $53.1m0.35% 0.35% AddedShares held: Q3 2020 16.6m, Q4 2020 16.6m, Q1 2021 16.6m, Q2 2021 33.2m +16.6m +16,584,802 100.0%
71 REPLIGEN CORP COM RGEN RGEN 265,000 $52.9m0.34% 0.34% NewShares held: Q3 2020 0, Q4 2020 97.5k, Q1 2021 0, Q2 2021 265.0k
72 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 630,282 $52.2m0.34% 0.34% AddedShares held: Q3 2020 0, Q4 2020 1.1m, Q1 2021 409.3k, Q2 2021 630.3k +220.9k +220,941 54.0%
73 LYRA THERAPEUTICS INC COM LYRA LYRA 6,445,120 $51.8m0.34% 0.34% AddedShares held: Q3 2020 3.2m, Q4 2020 3.2m, Q1 2021 3.2m, Q2 2021 6.4m +3.2m +3,222,560 100.0%
74 COGENT BIOSCIENCES INC COM COGT COGT 6,377,500 $51.7m0.34% 0.34% AddedShares held: Q3 2020 0, Q4 2020 3.2m, Q1 2021 3.2m, Q2 2021 6.4m +3.2m +3,188,750 100.0%
75 PMV PHARMACEUTICALS INC COM PMVP PMVP 1,493,114 $51.0m0.33% 0.33% AddedShares held: Q3 2020 605.6k, Q4 2020 885.6k, Q1 2021 746.6k, Q2 2021 1.5m +746.6k +746,557 100.0%
76 INHIBRX INC COM INBX INBX 1,814,180 $49.9m0.32% 0.32% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.8m
77 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 1,485,398 $49.7m0.32% 0.32% NewShares held: Q3 2020 49.8k, Q4 2020 0, Q1 2021 0, Q2 2021 1.5m
78 COLLEGIUM PHARMACEUTICAL INC COM COLL COLL 1,956,554 $46.3m0.30% 0.30% AddedShares held: Q3 2020 2.1m, Q4 2020 2.1m, Q1 2021 978.3k, Q2 2021 2.0m +978.3k +978,277 100.0%
79 FORTE BIOSCIENCES INC COM COM 1,370,000 $46.1m0.30% 0.30% AddedShares held: Q3 2020 0, Q4 2020 350.0k, Q1 2021 685.0k, Q2 2021 1.4m +685.0k +685,000 100.0%
80 STOKE THERAPEUTICS INC COM STOK STOK 1,343,956 $45.2m0.29% 0.29% AddedShares held: Q3 2020 672.0k, Q4 2020 672.0k, Q1 2021 672.0k, Q2 2021 1.3m +672.0k +671,978 100.0%
81 AGILE THERAPEUTICS INC COM AGRX AGRX 31,839,850 $42.3m0.28% 0.28% AddedShares held: Q3 2020 15.9m, Q4 2020 15.9m, Q1 2021 15.9m, Q2 2021 31.8m +15.9m +15,919,925 100.0%
82 VYNE THERAPEUTICS INC COM COM 11,547,908 $40.5m0.26% 0.26% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 6.8m, Q2 2021 11.5m +4.8m +4,773,954 70.5%
83 ONCORUS INC COM COM 2,927,198 $40.4m0.26% 0.26% AddedShares held: Q3 2020 0, Q4 2020 2.0m, Q1 2021 2.0m, Q2 2021 2.9m +937.2k +937,211 47.1%
84 CLOVER HEALTH INVESTMENTS CO COM CL A CLOV CLOV 3,000,000 $40.0m0.26% 0.26% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 1.5m, Q2 2021 3.0m +1.5m +1,500,000 100.0%
85 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 5,777,778 $37.8m0.25% 0.25% AddedShares held: Q3 2020 2.9m, Q4 2020 2.9m, Q1 2021 2.9m, Q2 2021 5.8m +2.9m +2,888,889 100.0%
86 DAY ONE BIOPHARMACEUTICALS I COM COM 1,512,094 $34.4m0.22% 0.22% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.5m
87 1LIFE HEALTHCARE INC COM COM 1,032,088 $34.1m0.22% 0.22% AddedShares held: Q3 2020 279.8k, Q4 2020 519.8k, Q1 2021 519.8k, Q2 2021 1.0m +512.2k +512,244 98.5%
88 CM LIFE SCIENCES II INC UNIT 02/25/2028 UNIT 02/25/2028 2,500,000 $33.6m0.22% 0.22% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 1.2m, Q2 2021 2.5m +1.2m +1,250,000 100.0%
89 CATABASIS PHARMACEUTICALS IN COM NEW CATB CATB 15,374,370 $32.4m0.21% 0.21% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 1.9m, Q2 2021 15.4m +13.4m +13,440,819 695.1%
90 NANOSTRING TECHNOLOGIES INC NOTE 2.625% 3/0 · principal NSTG 2.625 03.01.25 · principal NSTG 2.625 03.01.25 2,000,000 $32.4m0.21% 0.21% NewPrincipal held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 2.0m
91 IMMUNOCORE HLDGS PLC ADS IMCR IMCR 800,000 $31.2m0.20% 0.20% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 400.0k, Q2 2021 800.0k +400.0k +400,000 100.0%
92 NEPTUNE WELLNESS SOLUTIONS I COM NEPT NEPT 25,699,412 $30.1m0.20% 0.20% AddedShares held: Q3 2020 19.4m, Q4 2020 22.2m, Q1 2021 12.8m, Q2 2021 25.7m +12.8m +12,849,706 100.0%
93 ACLARIS THERAPEUTICS INC COM ACRS ACRS 1,700,000 $29.9m0.19% 0.19% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 650.0k, Q2 2021 1.7m +1.1m +1,050,000 161.5%
94 HEALTHCOR CATALIO ACQU CORP CL A SHS HYPR HYPR 3,000,000 $29.6m0.19% 0.19% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 1.5m, Q2 2021 3.0m +1.5m +1,500,000 100.0%
95 NANOBIOTIX SPONSORED ADS NBTX NBTX 2,119,600 $29.2m0.19% 0.19% AddedShares held: Q3 2020 0, Q4 2020 1.1m, Q1 2021 1.1m, Q2 2021 2.1m +1.1m +1,059,800 100.0%
96 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 1,589,012 $29.1m0.19% 0.19% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.6m
97 ADAPTIVE BIOTECHNOLOGIES COR COM ADPT ADPT 705,608 $28.8m0.19% 0.19% AddedShares held: Q3 2020 830.0k, Q4 2020 904.9k, Q1 2021 352.8k, Q2 2021 705.6k +352.8k +352,804 100.0%
98 VIATRIS INC COM VTRS VTRS 2,008,838 $28.7m0.19% 0.19% AddedShares held: Q3 2020 0, Q4 2020 1.0m, Q1 2021 1.0m, Q2 2021 2.0m +1.0m +1,004,419 100.0%
99 FUSION PHARMACEUTICALS INC COM COM 3,550,334 $28.7m0.19% 0.19% AddedShares held: Q3 2020 2.2m, Q4 2020 2.2m, Q1 2021 2.0m, Q2 2021 3.6m +1.6m +1,600,167 82.0%
100 LEAP THERAPEUTICS INC COM LPTX LPTX 16,952,992 $27.8m0.18% 0.18% AddedShares held: Q3 2020 8.5m, Q4 2020 8.5m, Q1 2021 8.5m, Q2 2021 17.0m +8.5m +8,476,496 100.0%

Sold out since Q1 2021

SecurityTickerShares held beforeValue then
ALLOGENE THERAPEUTICS INC ALLO ALLO 1,143,790 $40.4m1.1m shares
ARENA PHARMACEUTICALS INC ARNA ARNA 575,007 $39.9m575.0k shares
ACADIA PHARMACEUTICALS INC ACAD ACAD 1,410,305 $36.4m1.4m shares
FORMA THERAPEUTICS HLDGS INC 1,250,000 $35.0m1.2m shares
COMPASS PATHWAYS PLC CMPS CMPS 797,404 $29.4m797.4k shares
VAXCYTE INC PCVX PCVX 850,000 $16.8m850.0k shares
SYNDAX PHARMACEUTICALS INC SNDX SNDX 270,000 $6.0m270.0k shares
VINCERX PHARMA INC 300,000 $5.8m300.0k shares
PHREESIA INC PHR PHR 100,000 $5.2m100.0k shares
DEERFIELD HEALTHCARE TECH AC 300,000 $3.9m300.0k shares
THERAPEUTICSMD INC TXMD TXMD 2,750,000 $3.7m2.8m shares
VIEWRAY INC VRAYQ VRAYQ 751,748 $3.3m751.7k shares
TALIS BIOMEDICAL CORP 250,000 $3.2m250.0k shares
VINCERA PHARMA INC 300,000 $1.2m300.0k shares
CEL-SCI CORP 33,700 $513.0k33.7k shares
SANA BIOTECHNOLOGY INC SANA SANA 10,000 $335.0k10.0k shares
DEERFIELD HEALTHCARE TECH AC 20,000 $242.0k20.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
TELADOC HEALTH INC TDOC · Call TDOCCall 200,000 $33.3m200.0k shares New
RAPT THERAPEUTICS INC Put Put 90,000 $166.0k90.0k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on. The largest 25 of 38.

CompanyTickerStakeChange ScheduleLast filed
ADAGIO MED HLDGS INC ADGM · 13G · filed 2026-05-15 ADGM 55.4%≈ $8.8m -2.1 pts 13G 2026-05-15
LEONABIO INC LONA · 13D · filed 2026-10-26 LONA 20.0%≈ $17.4m no change 13D 2026-10-26
LYRA THERAPEUTICS INC LYRA · 13D · filed 2025-08-14 LYRA 15.6% 13D 2025-08-14
MEIRAGTX HLDGS PLC MGTX · 13D · filed 2026-04-24 MGTX 12.6%≈ $158.6m -0.3 pts 13D 2026-04-24
SOLID BIOSCIENCES INC SLDB · 13D · filed 2026-08-14 SLDB 11.2%≈ $120.3m -1.7 pts 13D 2026-08-14
PERCEPTIVE CAP SOLUTIONS COR FRNM · 13G · filed 2026-07-23 FRNM 10.1% new 13G 2026-07-23
INHIBRX BIOSCIENCES INC INBX · 13G · filed 2026-08-14 INBX 10.0%≈ $141.1m no change 13G 2026-08-14
ALTO NEUROSCIENCE INC ANRO · 13G · filed 2026-08-14 ANRO 10.0%≈ $110.2m no change 13G 2026-08-14
OPUS GENETICS INC IRD · 13G · filed 2026-08-14 IRD 10.0%≈ $37.6m no change 13G 2026-08-14
ENGENE HOLDINGS INC 13G · filed 2026-08-14 10.0% no change 13G 2026-08-14
KIORA PHARMACEUTICALS INC KPRX · 13G · filed 2026-08-10 KPRX 10.0%≈ $1.2m new 13G 2026-08-10
ENVVENO MEDICAL CORPORATION 13G · filed 2026-02-17 10.0% 13G 2026-02-17
ORCHESTRA BIOMED HLDGS INC OBIO · 13G · filed 2025-11-14 OBIO 10.0%≈ $24.5m 13G 2025-11-14
TRINITY BIOTECH PLC 13D · filed 2026-05-04 9.9% no change 13D 2026-05-04
OUTSET MED INC OM · 13G · filed 2025-02-28 OM 9.5% new 13G 2025-02-28
NAUTILUS BIOTECHNOLOGY INC NAUT · 13D · filed 2026-08-14 NAUT 9.1%≈ $21.8m -1.0 pts 13D 2026-08-14
KARDIGAN INC KARD · 13D · filed 2026-10-01 KARD 8.8%≈ $196.9m -0.1 pts 13D 2026-10-01
QUINCE THERAPEUTICS INC IRLA · 13G · filed 2026-10-14 IRLA 8.4%≈ $1.7m new 13G 2026-10-14
RESEARCH ALLIANCE CORP III RACC · 13G · filed 2026-05-28 RACC 8.2%≈ $8.0m new 13G 2026-05-28
X4 PHARMACEUTICALS INC XFOR · 13G · filed 2026-08-14 XFOR 8.1%≈ $37.8m +0.8 pts 13G 2026-08-14
SUTRO BIOPHARMA INC STRO · 13G · filed 2026-08-14 STRO 7.9%≈ $43.3m +2.5 pts 13G 2026-08-14
PALISADE BIO INC PALI · 13G · filed 2026-05-15 PALI 7.9%≈ $29.5m -2.1 pts 13G 2026-05-15
IMMATICS N.V IMTX · 13D · filed 2026-08-27 IMTX 7.6%≈ $113.5m 13D 2026-08-27
AMYLYX PHARMACEUTICALS INC AMLX · 13G · filed 2026-05-15 AMLX 7.5%≈ $148.8m -0.7 pts 13G 2026-05-15
SAB BIOTHERAPEUTICS INC SABS · 13G · filed 2026-08-14 SABS 7.3%≈ $25.8m -1.1 pts 13G 2026-08-14

Trades reported as a company insider in Q2 2021

Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.

DateCompanyTickerTradeShares ValueTheir holding
2021-06-09 NAUTILUS BIOTECHNOLOGY INC Former Director · See Footnote NAUT Bought 5,500,000 $55.0m5.5m shares +1107%
2021-06-03 NAUTILUS BIOTECHNOLOGY INC Director · See Footnote NAUT Bought 330,050 $3.3m330.1k shares +206%
2021-05-24 NAUTILUS BIOTECHNOLOGY INC Former Director NAUT Bought 7,063 $71.0k7.1k shares +1%
2021-05-20 NAUTILUS BIOTECHNOLOGY INC Director · See Footnote NAUT Bought 159,925 $1.6m159.9k shares new
2021-05-03 ALDEYRA THERAPEUTICS INC 10% owner · See Footnote ALDX Bought 1,200,000 $15.0m1.2m shares +14%